Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
To learn more about the new BALANCE model, including who qualifies for it, keep reading
- For claims under the 340B Drug Pricing Program, modifiers such as "JG" or "TB" must be used when applicable, per CMS requirements from 2023 onward
Mutagenesis and cAMP signaling assays confirmed the functional importance of these interactions, providing a molecular blueprint for Retatrutides potent and balanced activity
Cardiovascular risk2.4mg/wk The dose tested in the cardiovascular outcomes trial, which cut major adverse cardiovascular events by 20% in people with established cardiovascular disease and no diabetes
US$ 25.52
US$ 23.43
US$ 25.96
US$ 27.08
US$ 23.93
US$ 21.37
US$ 23.40
US$ 23.33
US$ 23.18
US$ 23.28
